Bank of Nova Scotia
GILD icon

Bank of Nova Scotia’s Gilead Sciences GILD Stock Holding History

Bank of Nova Scotia’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-40,000
Closed -$4.05M – 733
2015
Q4 		$4.05M Hold
40,000
– – 0.02% 267
2015
Q3 		$3.93M Buy
+40,000
New +$4.44M 0.02% 214

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of Nova Scotia's GILD Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Gilead Sciences (GILD) stake by 41% in Q1 2026, selling an estimated $70.6M and leaving 723,376 shares worth $101M. The position accounts for 0.18% of the portfolio, ranked #105.

Bank of Nova Scotia first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $151M in Q4 2025. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bank of Nova Scotia held 723,376 shares of Gilead Sciences worth $101M as of Q1 2026.
  • Bank of Nova Scotia sold 503,903 Gilead Sciences shares in Q1 2026, an estimated $70.6M.
  • Gilead Sciences made up 0.18% of Bank of Nova Scotia's portfolio in Q1 2026, its #105 holding.
  • Bank of Nova Scotia first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Gilead Sciences position peaked at $151M in Q4 2025.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.